Skip to main content
Steven Pipe, MD, Pediatric Hematology & Oncology, Ann Arbor, MI

StevenWPipeMD

Pediatric Hematology & Oncology • Ann Arbor, MI

Pediatric Coagulation Disorder Hematology, Pediatric Platelet Disorder Hematology

Professor, Pediatrics & Communicable Diseases, University of Michigan Medical School

Join to view full profile

Dr. Pipe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pipe's full profile

Already have an account?

  • Office

    1500 E Medical Center Dr
    D4207 MPB
    Ann Arbor, MI 48109
    Phone+1 734-232-9335
    Fax+1 734-615-0464

Education & Training

  • University of Michigan
    University of MichiganFellowship, Pediatric Hematology/Oncology, 1993 - 1996
  • University of Toronto Faculty of Medicine
    University of Toronto Faculty of MedicineClass of 1989

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1996 - 2025
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • One Year Data from a Phase 2b Trial of AMT-061 (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults with Severe or Moderate-Severe Hemophilia B
    Steven Pipe, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Moving Beyond Factor: Shifting the Paradigm in Hemophilia Through Gene Therapy 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Fitusiran, an RNAi Therapeutic Targeting Antithrombin to Restore Hemostatic Balance in Patients with Hemophilia a or B with or without Inhibitors: Management of Acute ... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • First-in-human Gene Therapy Study of AAVhu37 Capsid Vector Technology in Severe Hemophilia A 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • CSL Reports Promising Four-Year Data on Gene Therapy for Hemophilia B
    CSL Reports Promising Four-Year Data on Gene Therapy for Hemophilia BFebruary 9th, 2025
  • Gene Therapy Can Transform Life for People with Hemophilia. But Some Patients Don’t Want It
    Gene Therapy Can Transform Life for People with Hemophilia. But Some Patients Don’t Want ItJanuary 29th, 2023
  • Most Patients Bleed-Free at 3 Years After Roctavian in GENEr8-1 Trial
    Most Patients Bleed-Free at 3 Years After Roctavian in GENEr8-1 TrialJanuary 13th, 2023
  • Join now to see all

Dr. Steven Pipe, Dr. Steven Pipe, MD, Dr. S Pipe, Dr. Steven W Pipe